Publications

Export results as:

Showing 41 - 50 results of 5691

2024

The effect of temporal data aggregation to assess the impact of changing temperatures in Europe: an epidemiological modelling study

The Lancet Regional Health - Europe

J. Ballester, K. Robin van Daalen, Z-Y. Chen, H. Achebak, J. M. Antó, X. Basagaña, J-M. Robine, F. R. Herrmann, C. Tonne, J. C. Semenza, and R. Lowe
Rare disease research workflow using multilayer networks elucidates the molecular determinants of severity in Congenital Myasthenic Syndromes

Nature Communications

I. Núñez-Carpintero, M. Rigau, M. Bosio, E. O'Connor, S. Spendiff, Y. Azuma, A. Topf, R. Thompson, T. Chamova, I. Tournev, V. Guergueltcheva, S. Laurie, S. Beltran, S. Capella-Gutierrez, D. Cirillo, H. Lochmüller, and A. Valencia
A high-performance electromagnetic code to simulate high-temperature superconductors

Fusion Engineering and Design

A. Soba, O. Fernandez-Serracanta, J. Lorenzo, D. Garcín, G. Houzeaux, N. Lamas, X. Granados, and M. J. Mantsinen
Hypertriton lifetime

Physical Review C

D.. Gazda, A.. Pérez-Obiol, E.. Friedman, and A.. Gal
Novel genotype–phenotype correlations, differential cerebellar allele‑specific methylation, and a common origin of the (ATTTC)n insertion in spinocerebellar ataxia type 37

Human Genetics

M. Sanchez-Flores, , E. Gasch-Navalón, D. Cirillo, I. Sanchez, and A. Matilla-Dueñas
Modeling of frequency-sweeping Alfvén modes in the TJ-II stellarator

Nuclear Fusion

A. G. Ghiozzi, M. J. Mantsinen, P. Pastells, D. A. Spong, A. V. Melnikov, L. E. Eliseev, and S. E. Sharapov
WOMBAT-P: Benchmarking Label-Free Proteomics Data Analysis Workflows

Journal of Proteome Research

D. Bouyssié, P. Altıner, S. Capella-Gutierrez, J. M. Fernández, Y. Paco Hagemeijer, P. Horvatovich, M. Hubálek, F. Levander, P. Mauri, M. Palmblad, W. Raffelsberger, L. Rodriguez-Navas, D. Di Silvestre, B. Tibor Kunkli, J. Uszkoreit, Y. Vandenbrouck, J. Antonio Vizcaíno, D. Winkelhardt, and V. Schwämmle
Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA)

Vaccines

I. Esteban, C. Pastor-Quiñones, L. Usero, E. Aurrecoechea, L. Franceschini, A. Esprit, J. Lluis Gelpí, F. Martínez-Jiménez, N. López-Bigas, K. Breckpot, K. Thielemans, L. Leal, C. Elena Gómez, M. Sisteré-Oró, A. Meyerhans, M. Esteban, M. José Alonso, F. García, and M. Plana

2023

Pages